Meet Batch #2

We help to understand and improve the performance, efficiency and lifetime of batteries. Our platform accurately determines and forecasts the health of batteries using laboratory and operational data.

We are developing a software, that discovers and utilizes automation potential. It discovers potential for automation on its own and also offers actionable suggestions right in the frontend of the user.

We are building a distributed Edge Database Platform as a Service for developers that works across clouds and edge. It can be used as the data management service in areas of activity developing a cloud solution.

Our product is a complete medical collaboration platform delivered as a single, decentralized application that is transforming the way healthcare professionals collaborate and share data.

We use a highly productive and patented spinning technology to produce inexpensive high-performance composite fibers.

We develop the next generation of magnetic resonance imaging (MRI) solutions to take MRI diagnostics to the next level. We offer real-time control of the MRI magnetic field with a compact plug and play device.

We develop products and processes that will enable our customers to steer bioprocesses with multi-parameter control using light, which will in return allow them to produce new kinds of biopharmaceuticals.

We help companies reduce their travel cost and associated CO2 footprint by rewarding employees when they help achieve those Goals.

We develop and license algorithms for hearables and hearing aids that help users communicate. Our core technology solves a common effect when wearing headphones where one’s own voice sounds distorted.

With our artificial intelligence, it is possible for the first time to analyze 3D scans fully automatically, recognize objects and, without manual intervention, create models for use in planning and simulation Tools.

We develop an innovative hybrid vehicle for seamless mobility which leads to the mastering of urban traffic problems and realizing savings potentials for cities and industrial companies.

We aim to change the red biotechnology production sector, with a platform technology in the field of analytical devices. We will improve data quality in bioreactor systems through the application of innovative sensors.